Skip to main content
. 2018 May 19;25(1):1127–1136. doi: 10.1080/10717544.2018.1469688

Table 1.

Experimental design of inhaled vs. IV topotecan for the treatment of lung tumors in rats.

Group Lung cancer Cell line Number of rats Treatments**
Vehicle 2 mg/kg IV 1 mg/kg inhalation
1 None* 6
2 A549 15 +
3 15 +
4 15 +
5 H1975 15 +
6 15 +
7 15 +
*

Animals in Group 1 serve as cancer-free and treatment-free control.

**

The ‘+’ and ‘−’ signs indicate the treatments given or not given, respectively.